Anand Pathak, Angela S Wenzlaff, Paula L Hyland, Michele L Cote, Greg R Keele, Susan Land, Matthew L Boulton, Ann G Schwartz
{"title":"Apoptosis-Related Single Nucleotide Polymorphisms and the Risk of Non-Small Cell Lung Cancer in Women.","authors":"Anand Pathak, Angela S Wenzlaff, Paula L Hyland, Michele L Cote, Greg R Keele, Susan Land, Matthew L Boulton, Ann G Schwartz","doi":"10.7243/2049-7962-3-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Germline apoptosis-related single nucleotide polymorphisms (SNPs) have been shown to contribute to the risk of developing non-small cell lung cancer (NSCLC). However, very few studies have looked specifically at apoptosis-related SNPs in a racially-stratified analysis of white and African-American women.</p><p><strong>Methods: </strong>We examined the risk of developing NSCLC associated with 98 germline SNPs in 32 apoptosis-related genes among women in a population-based case-control study from the Detroit metropolitan area. We examined 453 cases of NSCLC and 478 control subjects. We used an unconditional logistic regression with a dominant model, stratified by race, and adjusted for age, pack-years smoked, ever/never smoking status, family history of lung cancer, history of COPD, BMI and education.</p><p><strong>Results: </strong>Our logistic regression identified 3 significant apoptosis-related SNPs in whites (<i>APAF-1,</i> rs1007573; <i>CD40</i> rs3765459, and <i>CD40</i> rs1535045), and 7 significant SNPs (<i>ATM,</i> rs1801516; <i>BAK1,</i> rs513349; <i>TNF,</i> rs1800629; <i>TP63,</i> rs6790167; <i>TP63,</i> rs7613791, <i>TP63,</i> rs35592567 and <i>TP63,</i> rs3856775<i>)</i> in African-Americans. In a downstream analysis, these SNPs were further prioritized utilizing the False Positive Report Percentage (FPRP) methodology and backwards elimination. In whites, <i>APAF-1 (</i>rs1007573), <i>CD40 (</i>rs3765459) and <i>CD40</i> (rs1535045) were all found to be significant by FPRP. In African-Americans, <i>TP63</i> SNPs rs6790167 and rs7613791 were found to have a significant FPRP. In parallel, a backward elimination procedure was used on the 3 significant SNPs in whites and 7 significant SNPs in African-Americans. This procedure identified <i>APAF-1</i> rs1007573 (OR=1.86, 95% CI: 1.17-2.95) and <i>CD40</i> rs1535045 (OR=0.58, 95% CI: 0.40-0.84) as significant independent predictors of risk among whites, and <i>ATM</i> rs1801516 (OR=24.15, 95% CI: 3.50-166.55), <i>TNF</i> rs1800629 (OR= 0.42, 95% CI: 0.18-0.99) and <i>TP63</i> rs6790167 (OR: 2.85, 95% CI: 1.33-6.09) as significant, independent predictors in African-Americans.</p><p><strong>Conclusion: </strong>In whites, only SNPs <i>APAF-1</i> rs1007573 and <i>CD40</i> rs1535045 were significant by both FPRP and backwards elimination, while in African-Americans, only <i>TP63</i> rs6790167 was significant by both methodologies. Thus, we have identified three promising variants associated with increased risk of NSCLC that warrant additional investigation in future studies.</p>","PeriodicalId":90206,"journal":{"name":"Journal of cancer therapeutics & research","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002173/pdf/nihms-559787.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer therapeutics & research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7243/2049-7962-3-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Germline apoptosis-related single nucleotide polymorphisms (SNPs) have been shown to contribute to the risk of developing non-small cell lung cancer (NSCLC). However, very few studies have looked specifically at apoptosis-related SNPs in a racially-stratified analysis of white and African-American women.
Methods: We examined the risk of developing NSCLC associated with 98 germline SNPs in 32 apoptosis-related genes among women in a population-based case-control study from the Detroit metropolitan area. We examined 453 cases of NSCLC and 478 control subjects. We used an unconditional logistic regression with a dominant model, stratified by race, and adjusted for age, pack-years smoked, ever/never smoking status, family history of lung cancer, history of COPD, BMI and education.
Results: Our logistic regression identified 3 significant apoptosis-related SNPs in whites (APAF-1, rs1007573; CD40 rs3765459, and CD40 rs1535045), and 7 significant SNPs (ATM, rs1801516; BAK1, rs513349; TNF, rs1800629; TP63, rs6790167; TP63, rs7613791, TP63, rs35592567 and TP63, rs3856775) in African-Americans. In a downstream analysis, these SNPs were further prioritized utilizing the False Positive Report Percentage (FPRP) methodology and backwards elimination. In whites, APAF-1 (rs1007573), CD40 (rs3765459) and CD40 (rs1535045) were all found to be significant by FPRP. In African-Americans, TP63 SNPs rs6790167 and rs7613791 were found to have a significant FPRP. In parallel, a backward elimination procedure was used on the 3 significant SNPs in whites and 7 significant SNPs in African-Americans. This procedure identified APAF-1 rs1007573 (OR=1.86, 95% CI: 1.17-2.95) and CD40 rs1535045 (OR=0.58, 95% CI: 0.40-0.84) as significant independent predictors of risk among whites, and ATM rs1801516 (OR=24.15, 95% CI: 3.50-166.55), TNF rs1800629 (OR= 0.42, 95% CI: 0.18-0.99) and TP63 rs6790167 (OR: 2.85, 95% CI: 1.33-6.09) as significant, independent predictors in African-Americans.
Conclusion: In whites, only SNPs APAF-1 rs1007573 and CD40 rs1535045 were significant by both FPRP and backwards elimination, while in African-Americans, only TP63 rs6790167 was significant by both methodologies. Thus, we have identified three promising variants associated with increased risk of NSCLC that warrant additional investigation in future studies.